InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Explore the detailed record of transactions filed by Mahmood Ladha. Director active across 1 company, notably Swedish Orphan Biovitrum AB (publ). Aggregated, 5 filings have been logged. Activity tracked since 24 October 2025. The latest transaction was disclosed on 21 July 2026 (Purchase). Regulator: FIN-FSA. The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条